Skip to main content
ConductScienceScienceDex

Nouri Neamati

NIH Rank #9557
Unclaimed recordClaim profile
  • R01 Holder
  • Translational
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6663522Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology
  • Pathology

NIH Funding · FY2025

Linked Award Amount
$1.6M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#9,557
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Nouri Neamati. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Nouri Neamati as a PI. Multi-PI records show the full award amount for context.

  • 4R01CA266513-04R01
    Preclinical Development of First-in-Class GSTO1 Degraders for Colorectal Cancer
    University of Michigan
    $1.1M
    award amount
  • 5R01CA272641-04R01
    Preclinical Development of First-in-Class NDUFS7 Antagonists for the Treatment of Pancreatic Cancer
    University of Michigan
    $472.5K
    award amount
  • 5R01CA253986-04R01
    SIRT5 inhibitors and degraders as novel treatments for Ewing sarcoma
    University of Miami School of Medicine
    $1
    award amount

Award organizations

Organizations that administered FY2025 awards listing Nouri Neamati as a PI.

University of Michigan
MI
$1.6M
2 grants
University of Miami School of Medicine
FL
$1
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Michigan
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #9066
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  7. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Nouri Neamati.

David Benner Lombard
University of Miami School of Medicine
3
shared awards

Explore further

Find collaborators for Nouri Neamati

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →